COVID-19 vaccine manufacturer Pfizer Inc. says they’re “proud to stand with China” in connection with the use of the Chinese Communist Party’s payment platform, which is being used for vaccine passports.
QUICK FACTS:
- Vaccine manufacturing giant Pfizer has been found to be a partner with the Chinese Communist Party (CCP) in the use of Alipay, a Chinese digital payment platform, according to The National Pulse.
- A tweet from 2018 had announced the cooperation between Pfizer and the company, founded as an offshoot of the CCP-linked company Alibaba.
- During the announcement of the partnership, Pfizer said it was proud to stand with China leaders and @Alipay to introduce new digital solutions to improve disease education and vaccine access, creating a “brighter future for Chinese children.”
- The notification also includes details about Pfizer’s cooperation with China’s “Internet + Vaccination” initiative.
- Alipay has been flagged by the State Department as a known “tool” of the CCP for aiding in the build-up of “technology-facilitated surveillance and social control.”
MORE ABOUT THE COMPANY:
- According to the Assistant Secretary for International Security and Nonproliferation at the U.S. State Department Christopher Ford, Alibaba has long been suspected of multiple dangerous activities.
- Ford indicated the parent company was involved in the research, production, and repair of weapons and equipment for the People’s Liberation Army (PLA).
- The group also reportedly has a “deep record of cooperation and collaboration” with China’s “state security bureaucracy.”
BACKGROUND:
- Pfizer began its partnership with the company in 2018, despite these questionable ties to the communist regime.
- Details of the partnership were outlined in the company’s annual review, in which they stated that they were using the Alipay platform to provide education about disease and vaccinations.
- Pfizer also said that they planned to use its connection to the nation to assist China in reaching its 2030 goals to reduce infant mortality.
- The pharmaceutical giant also said they would attempt to use the platform for mobile payments for low-income families.
